The Pharma Data

NOVEMBER 4, 2020

TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced that it has entered into an exclusive agreement with Juyou-Biotechnology Co.

Licensing 40

Licensing Licensing Dermatology Production 40

XTalks

MAY 22, 2023

Allergan Aesthetics, an AbbVie company renowned for its development of leading aesthetics brands and products, recently announced the US Food and Drug Administration (FDA) approved their ground-breaking hyaluronic acid product, SkinVive by Juvéderm, for achieving remarkable skin smoothness.

Filler 92

Filler FDA Approval Dermatology In-Vivo 92

Druggist

DECEMBER 9, 2020

Clobetasone (brand name: Eumovate cream). Clobetasone (brand name: Eumovate) is the second steroid cream on the list, which is available over the counter. Clobetasone has a narrow licensed use. Dactacort has also antibacterial properties and is one of few over the counter creams licensed for bacterial infections.

Pharmacy 97

Pharmacy Containment Sales Production 97

Druggist

MARCH 17, 2021

Lymecycline is usually prescribed as a generic drug – lymecycline 408mg capsules or occasionally as a branded medication called Tetralysal 300 mg capsules. Although licensed for acne, minocycline is rarely prescribed in the UK. Benzoyl peroxide is sold to treat acne from pharmacies as a branded product called Acnecide 5% gel.

Bacteria 59

Bacteria Dermatology Doctors Doctor 59

The Pharma Data

FEBRUARY 5, 2021

American Society for Dermatologic Surgery (ASDS) consumer survey on cosmetic dermatologic procedures 2018 available at [link]. At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. For more information and to find a provider near you, visit [link].

Dermatology 52

Dermatology Cosmetics Allergies Production 52

pharmaphorum

APRIL 26, 2021

Merck licensed sonelokimab (M1095) from Ablynx in 2013, and four years later formed a partnership with Avillion to carry out phase 2 and 3 testing of the drug. Since then Novartis’ drug has grown into a $4 billion brand, while Taltz has also achieved blockbuster status, racking up $1.36 billion in sales last year.

Antibody 52

Antibody Drugs Marketing Licensing 52

The Pharma Data

APRIL 26, 2021

COVID-19 negatively impacted demand, particularly: dermatology, ophthalmology, the breast cancer portfolio, Sandoz Retail and Anti-Infectives. billion declined, mainly due to the USD 650 million upfront payment to in-license tislelizumab from BeiGene. Adakveo sales reached USD 37 million. Free cash flow¹ of USD 1.6 Tafinlar + Mekinist.

Sales 40

Sales Medicine Production Manufacturing 40